Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | USP2 | O75604 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31351432 | 0.86 | ALDH1A1 (0.37) | TSHRALDH1A1USP2HPGDCYP3A4 | |
| SCHEMBL31351422 | 0.83 | TSHR (0.38) | TSHRALDH1A1USP2HPGDCYP3A4 | |
| SCHEMBL31351425 | 0.78 | TSHR (0.35) | TSHRALDH1A1USP2HPGDCYP3A4 | |
| SCHEMBL4958552 | 0.78 | TSHR (0.38) | TSHRALDH1A1USP2HPGDCYP3A4 | |
| SCHEMBL4960214 | 0.78 | TSHR (0.38) | TSHRALDH1A1USP2HPGDCYP3A4 | |
| SCHEMBL153874 | 0.76 | TSHR (0.37) | TSHRALDH1A1USP2HPGDCYP3A4 | |
| SCHEMBL31351401 | 0.76 | TSHR (0.38) | TSHRALDH1A1USP2HPGDCYP3A4 | |
| SCHEMBL4186908 | 0.75 | TSHR (0.39) | TSHRALDH1A1USP2HPGDCYP3A4 | |
| SCHEMBL6865894 | 0.73 | TSHR (0.39) | TSHRALDH1A1USP2HPGDCYP3A4 | |
| SCHEMBL31351372 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7322927-B2 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2008-01-29 | — | — | US | disclosed |
| US-20060228748-A1 | Hybrid phthalocyanine derivatives and their uses | BIOSITE INCORPORATED | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060228748-A1 | Hybrid phthalocyanine derivatives and their uses | UACA, PHAX, PTBP1 | TSHR 3585/4885ALDH1A1 1368/4885USP2 4472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.